Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

20 Stocks Moving In Monday's Pre-Market Session

VRTX, DRD, PTCT, GPRO, AUPH, ADXS, T.CNQ, TTD

Gainers

  • TG Therapeutics Inc (NASDAQ: TGTX) rose 70.1 percent to $9.10 in pre-market trading after the company disclosed that Phase 3 GENUINE study met its primary endpoint.
  • Concert Pharmaceuticals Inc (NASDAQ: CNCE) rose 36.7 percent to $13.19 in pre-market trading. Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) announced plans to acquire CTP-656 from Concert Pharma for $160 million in cash and potential $90 million in milestones.
  • PTC Therapeutics, Inc. (NASDAQ: PTCT) shares rose 14.9 percent to $11.27 in pre-market trading. PTC Therapeutics reported FDA acknowledgment of NDA filing for Translarna.
  • Pernix Therapeutics Holdings Inc (NASDAQ: PTX) shares rose 14 percent to $4.39 in pre-market trading after gaining 6.35 percent on Friday.
  • Novan Inc (NASDAQ: NOVN) rose 12.7 percent to $7.20 in pre-market trading. Novan announced plans to continue SB204 development program.
  • Canadian Natural Resource Ltd (USA) (NYSE: CNQ) rose 9.5 percent to 34.17 in pre-market trading after gaining 3.27 percent on Friday.
  • Advaxis, Inc. (NASDAQ: ADXS) rose 9.5 percent to $10.10 in pre-market trading after the company reported the FDA acceptance of IND for ADXS-NEO. The company announced plans to initiate Phase 1 trial in 2017
  • PDL BioPharma Inc (NASDAQ: PDLI) shares rose 5.8 percent to $2.29 in pre-market trading after climbing 6.13 percent on Friday.
  • Snap Inc (NYSE: SNAP) rose 3.5 percent to $28.04 in pre-market trading after surging 10.66 percent on Friday. Needham initiated coverage on Snap with an Underperform rating.
  • Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) rose 5 percent to $5.05 in pre-market trading after gaining 6.18 percent on Friday.
  • United States Natural Gas Fund, LP (NYSE: UNG) shares rose 3.8 percent to $7.10 in pre-market trading after gaining 0.59 percent on Friday.
  • Oclaro, Inc. (NASDAQ: OCLR) rose 3.8 percent to $9.96 in pre-market trading after surging 8.11 percent on Friday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • Zosano Pharma Corp (NASDAQ: ZSAN) fell 12 percent to $2.43 in pre-market trading after gaining 6.56 percent on Friday.
  • Trade Desk Inc (NASDAQ: TTD) fell 9 percent to $40.62 in pre-market trading after rising 5.09 percent on Friday.
  • RH (NYSE: RH) shares fell 5.2 percent to $29.58 in the pre-market trading session after declining 0.03 percent on Friday.
  • Insys Therapeutics Inc (NASDAQ: INSY) fell 5 percent to $10.90 in pre-market trading after dropping 4.97 percent on Friday.
  • Seadrill Partners LLC (NYSE: SDLP) fell around 4.3 percent to $3.60 in pre-market trading after declining 3.59 percent on Friday.
  • DRDGOLD Ltd. (ADR) (NYSE: DRD) shares fell 4.2 percent to $4.99 in pre-market trading after rising 3.99 percent on Friday.
  • Credit Suisse Group AG (ADR) (NYSE: CS) fell 3.7 percent to $15.21 in pre-market trading after gaining 2.46 percent on Friday.
  • GoPro Inc. (NASDAQ: GPRO) shares fell 3.3 percent to $8.55 in pre-market trading. Goldman Sachs downgraded GoPro from Neutral to Sell.


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today